• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,243.34 -116.67
( -0.16%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
659.0470742
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
17.19
103704.91
EPS(TTM)
Face Value()
Div & Yield %
131.91
2
0.79
 

frontier capital ltd
Indo Rama Synthetics (India) consolidated net profit rises 25.57% in the March 2026 quarter
May 26,2026
Net profit of Indo Rama Synthetics (India) rose 25.57% to Rs 64.13 crore in the quarter ended March 2026 as against Rs 51.07 crore during the previous quarter ended March 2025. Sales rose 0.27% to Rs 1201.68 crore in the quarter ended March 2026 as against Rs 1198.47 crore during the previous quarter ended March 2025.

For the full year,net profit rose 10629.29% to Rs 150.21 crore in the year ended March 2026 as against Rs 1.40 crore during the previous year ended March 2025. Sales rose 15.29% to Rs 4910.06 crore in the year ended March 2026 as against Rs 4258.93 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1201.681198.47 0 4910.064258.93 15
OPM %8.526.86 -6.354.17 -
PBDT75.9863.40 20 200.6749.59 305
PBT64.1351.07 26 152.911.40 10822
NP64.1351.07 26 150.211.40 10629